10x Genomics (TXG) Capital Expenditures Growth (3y) (2021 - 2026)

10x Genomics (TXG) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn -16.04%
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 6.16%
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 20.95%
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn -
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn -84.33%
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 30.88%
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn -
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn -
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 111.15%
10 Teladoc Health 1.45 Bn 696.57 Mn 562.57 Mn -7.57%

Historic Data

Download Data
DateValue
Mar 31, 2026 -84.33%
Dec 31, 2025 -74.11%
Sep 30, 2025 26.54%
Jun 30, 2025 -66.05%
Mar 31, 2025 -49.87%
Dec 31, 2024 30.09%
Sep 30, 2024 -27.51%
Jun 30, 2024 -6.12%
Mar 31, 2024 -12.31%
Dec 31, 2023 26.71%
Sep 30, 2023 -280.47%
Jun 30, 2023 -27.30%
Mar 31, 2023 121.79%
Dec 31, 2022 41.37%
Sep 30, 2022 -101.88%
Jun 30, 2022 84.24%
Mar 31, 2022 66.92%
Dec 31, 2021 -227.08%